MedTrace Logo

Intent of Surgery for IPMN

NCT07216521 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-10-14

No results posted yet for this study

Summary

This multicenter retrospective observational cohort study seeks to:

1. Classify surgical intent in patients with resected Intraductal Papillary Mucinous Neoplasms (IPMN) and quantify the proportion of IPMN-associated cancers diagnosed as overt pancreatic cancer with incidental IPMN association on pathology.
2. Compare clinicopathologic features and outcomes between surveillance-detected and incidentally detected IPMN-derived pancreatic cancers.
3. Revise and redefine risk features limited to patients undergoing surgery for IPMN-related indications, identifying optimal predictors of malignant IPMN (high-grade dysplasia or invasive cancer).

Conditions

  • Intraductal Papillary Mucinous Neoplasm

Sponsors & Collaborators

Principal Investigators

  • Greg Sacks, MD MPH PhD · NYU Langone Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States
  • China
  • Germany
  • Italy
  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07216521 on ClinicalTrials.gov